Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Packer

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetesWilliam McCoull, Matthew S Addie, Alan M Birch, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 InhibitorsJeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Journal of Medicinal Chemistry|September 27, 2021
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPsJeffrey W Johannes, Amber Balazs, Derek Barratt, et al.
Journal of Medicinal Chemistry|January 27, 2025
Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion MutationsWilliam McCoull, Clare Thomson, Erin Braybrooke, et al.
Journal of Medicinal Chemistry|December 10, 2024
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective InhibitorJeffrey W Johannes, Amber Y S Balazs, Derek Barratt, et al.
Wiley Interdisciplinary Reviews. Computational Molecular Science|October 14, 2014
The Dalton quantum chemistry program systemKestutis Aidas, Celestino Angeli, Keld L Bak, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetesWilliam McCoull, Matthew S Addie, Alan M Birch, et al.
ACS Medicinal Chemistry Letters|November 21, 2017
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"Jeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 InhibitorsJeffrey W Johannes, Stephanie Bates, Carl Beigie, et al.
Journal of Medicinal Chemistry|September 27, 2021
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPsJeffrey W Johannes, Amber Balazs, Derek Barratt, et al.
Journal of Medicinal Chemistry|January 27, 2025
Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion MutationsWilliam McCoull, Clare Thomson, Erin Braybrooke, et al.
Journal of Medicinal Chemistry|December 10, 2024
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective InhibitorJeffrey W Johannes, Amber Y S Balazs, Derek Barratt, et al.
Wiley Interdisciplinary Reviews. Computational Molecular Science|October 14, 2014
The Dalton quantum chemistry program systemKestutis Aidas, Celestino Angeli, Keld L Bak, et al.
Pageof 5